---
title: "港股生物制药板块走高，百济神州涨 5.5%，腾盛博药涨近 4%，药明生物、云顶新耀、再鼎医药跟涨。"
description: "港股生物制药板块走高，百济神州涨 5.5%，腾盛博药涨近 4%，药明生物、云顶新耀、再鼎医药跟涨。"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/105710688.md"
published_at: "2024-01-10T01:48:18.000Z"
---

# 港股生物制药板块走高，百济神州涨 5.5%，腾盛博药涨近 4%，药明生物、云顶新耀、再鼎医药跟涨。

港股生物制药板块走高，百济神州涨 5.5%，腾盛博药涨近 4%，药明生物、云顶新耀、再鼎医药跟涨。

### Related Stocks

- [02269.HK - 药明生物](https://longbridge.com/zh-CN/quote/02269.HK.md)
- [02137.HK - 腾盛博药-B](https://longbridge.com/zh-CN/quote/02137.HK.md)
- [ZLAB.US - 再鼎医药](https://longbridge.com/zh-CN/quote/ZLAB.US.md)
- [WXXWY.US - 药明生物(ADR)](https://longbridge.com/zh-CN/quote/WXXWY.US.md)
- [09688.HK - 再鼎医药](https://longbridge.com/zh-CN/quote/09688.HK.md)
- [01952.HK - 云顶新耀](https://longbridge.com/zh-CN/quote/01952.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| CICC Reaffirms Their Buy Rating on Suzhou Ribo Life Science Co., Ltd. Class H (6938) | In a report released yesterday, from CICC maintained a Buy rating on Suzhou Ribo Life Science Co., Ltd. Class H, with a  | [Link](https://longbridge.com/zh-CN/news/276199846.md) |
| 14:33 ETKeep Memory Alive Honors Kenny Loggins and Hosts Star-Studded Lineup at 30th Anniversary of Power of Love Gala | Keep Memory Alive honored Kenny Loggins at the 30th anniversary Power of Love gala on February 14 at MGM Grand Garden Ar | [Link](https://longbridge.com/zh-CN/news/276075313.md) |
| Trump says federal government to step in to 'protect' Potomac river amid sewage leak | U.S. President Donald Trump announced that the federal government will intervene to protect the Potomac River following  | [Link](https://longbridge.com/zh-CN/news/276076304.md) |
| 09:57 ETCapital Living TV Series Spotlights Washington, DC Real Estate and Lifestyle on REAL Shows Network | REAL Shows Network has launched "Capital Living," a new TV series hosted by Jonathan Rundlett, focusing on Washington, D | [Link](https://longbridge.com/zh-CN/news/276139308.md) |
| Lightship Selects CRIO eSource and Site CTMS Platform to Support Scalable Trial Execution Across Its Expanding Site Network | Lightship Inc. has selected CRIO's integrated eSource and site CTMS platform to enhance trial execution across its expan | [Link](https://longbridge.com/zh-CN/news/276258845.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。